Another study by Burman and colleagues in 2018 compared the performance of ELISA, SIMOA, and Luminex xMAP for measuring CSF CHI3L1 levels in patients with Alzheimer’s disease. Here, CHI3L1 is linked to early-onset autosomal dominant Alzheimer disease.